Latest news with #MainLineHealth
Yahoo
01-07-2025
- Health
- Yahoo
Homecare Homebase Announces July 2025 Gold Standard Award Winner
DALLAS, July 1, 2025 /PRNewswire/ -- Homecare HomebaseSM (HCHB), the leading software provider for home-based care, has named Meghan Pedley, Occupational Therapist at Main Line Health HomeCare & Hospice, as the July Gold Standard Award Winner. "Meghan is an outstanding therapist who especially excels in interdisciplinary collaborations. She is a teammate anyone would be happy to have," said leaders at Main Line Health. "She uses resources to demonstrate the skilled care delivered during her occupational therapy visits, and her chart audits reflect both her clinical expertise and commitment to excellence." The Gold Standard celebrates outstanding home-based caregivers who utilize HCHB to deliver exceptional patient care. Nominees are submitted by their agency leaders and meticulously chosen by the HCHB team for their expertise, enthusiasm and steadfast dedication. Pedley was selected as this month's Gold Standard Award winner for her outstanding patient care, effective use of HCHB technology and leadership in training new staff and supporting coordinated, high-quality care. "Meghan embodies what it means to deliver high-quality, patient-centered care," said leaders at Main Line Health. "Her knowledge, leadership, and attention to detail are apparent in every interaction. By combining clinical skill with compassion and teamwork, she consistently makes a positive impact on both her patients and colleagues." To learn more about these companies, visit and About Homecare Homebase, LLC Founded by industry veterans in 1999, Homecare HomebaseSM (HCHB) is a Dallas-based software leader empowering exceptional home-based care through hosted, cloud-based technology solutions and administrative services. HCHB's customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting and improved revenue cycle management. HCHB's products and services streamline operations, simplify compliance and boost clinical and financial outcomes for home-based care agencies. Each year, over 300,000 HCHB users serve approximately one million patients daily, resulting in over 121 million annual visits. Homecare Homebase is a Hearst Health company. For more information, visit or call us toll-free at 1-866-535-HCHB (4242). About Hearst Health The mission of Hearst Health is to guide healthcare organizations by delivering essential intelligence and software that improve the quality, safety and efficiency of care. Hearst Health has been innovating with care for more than 40 years, with a commitment to making a lasting positive impact on health. The Hearst Health companies — FDB, Homecare Homebase, MCG, MHK, QGenda and Zynx Health — elevate care by informing and empowering participants across the health journey. To learn more, visit and follow @Hearst Health on LinkedIn. About Main Line Health Founded in 1985, Main Line Health is a not-for-profit health system serving Philadelphia and its suburbs. Main Line Health's commitment — to deliver safe, high-quality, equitable and affordable care for treating and curing disease, playing an important role in prevention and disease management, as well as training physicians and other health care providers — reflects our intent to be the region's premier choice for clinical care, research, and education. A team of more than 13,000 employees and over 2,100 employed and independent physicians and advanced practice providers care for patients throughout Main Line Health. At Main Line Health's core are four of the region's most respected acute care hospitals — Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital — as well as one of the nation's premier facilities for rehabilitative medicine, Bryn Mawr Rehab Hospital. Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region's largest multispecialty physician networks. Main Line Health is the recipient of numerous awards for quality care and service, including the prestigious American Hospital Association Quest for Quality Prize, highest tier ratings from the Centers for Medicare & Medicaid Services (CMS) for Overall Hospital Quality and system wide recognition in the 2023-2024 U.S. News & World Report Best Hospitals rankings. Main Line Health is committed to creating an environment of diversity, respect, equity and inclusion, has proudly received awards in this area and has embraced the American Hospital Association's #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education and research to help patients stay healthy and live their best lives. For more information, visit View original content to download multimedia: SOURCE Homecare Homebase Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CBS News
19-05-2025
- Health
- CBS News
Pennsylvania doctor breaks down former President Joe Biden's prostate cancer diagnosis
Support is pouring in across party lines for former President Joe Biden, who revealed Sunday he's battling aggressive prostate cancer. Doctors are optimistic about the prognosis for the 82-year-old. The former president's office said the cancer was diagnosed Friday, the news was released Sunday and then Monday morning, Biden posted on social media. "Cancer touches us all. Like so many of you, Jill and I have learned that we are strongest in the broken places," Biden wrote on social media. "Thank you for lifting us up with love and support." "We are seeing rises in certain subtypes," Dr. Erik Zeger, an oncologist with Main Line Health, said. "We're seeing a lot of young patients with colorectal cancer that's clearly rising in the past 20 years." A statement from Biden's office said he had urinary symptoms and was subsequently diagnosed with an aggressive form of prostate cancer that had spread to the bone. "That bone involvement can lead to, in some patients, pain [and] fractures," Zeger said. Zeger said that because Biden's cancer is hormone sensitive, it's usually treated with medications to block testosterone that fuels the cancer, but that therapy has its own issues. "The side effects of hot flashes, fatigue, memory loss are real, but the treatment can work for quite some time," Zeger said. Additional treatment options could include radiation and chemotherapy. The American Cancer Society says more than 313,000 new cases of prostate cancer will be diagnosed in the U.S. this year, and more than 35,000 men will die. The former president and his family are reviewing treatment options with physicians. "Many men can live for an excess of five years with stage 4 prostate cancer, about 30% will live beyond five years," Zeger said. Doctors say Biden's cancer probably spread because it was not detected early. He's 82 years old. Prostate screenings that include PSA blood tests and a physical exam are not recommended for men past the age of 70. Fighting cancer has been a personal mission for Biden. He launched the national Cancer Moonshot initiative in Philadelphia, calling for more research. It was inspired in large part by his late son, Beau, who died of brain cancer.
Business Wire
23-04-2025
- Business
- Business Wire
Main Line Health Secures CIO 100 Honors Through Deployment of the Elisity-Armis Integration
SAN FRANCISCO & SAN JOSE, Calif.--(BUSINESS WIRE)--Armis, the cyber exposure management & security company, and Elisity, a pioneer in identity-based microsegmentation, today announced the results driven by their strategic integration that delivers frictionless, centrally managed Zero Trust access across enterprise networks. With this, both companies would like to congratulate their joint customer Main Line Health, which recently earned the prestigious CIO 100 Award for 2025, following their CSO50 Award in 2024, for their innovative cybersecurity implementation leveraging both platforms. 'The synergy between Armis and Elisity has fortified defenses against targeted cyber threats, improving overall operational efficiency with added layers of security and visibility,' said Aaron Weismann, Chief Information Security Officer for Main Line Health, whose team earned both awards for their innovative cybersecurity work. 'Microsegmentation is a key strategy for accelerating our Zero Trust program.' Aaron Weismann will be sharing Main Line Health's innovative approaches to cybersecurity at the upcoming RSA Conference (RSAC 2025) in San Francisco. His session, "Dr. Darkness or: How We Learned to Stop Worrying and Love Downtimes" (Thursday, May 1, 8:30 AM - 9:20 AM PDT), will explore the organization's innovative approach to maintaining clinical operations during cyber disruptions. The session, which also features Main Line Health Program Manager Anthony Fiore, will highlight how solutions like the Armis and Elisity integration help healthcare organizations enhance cyber resilience. The integration provides visibility and control over the entire attack surface, enabling organizations to rapidly implement microsegmentation and prevent lateral movement attacks—the technique used in over 70% of successful breaches, according to recent industry reports. This powerful combination addresses the critical challenges faced by manufacturing, healthcare, and industrial organizations as cyber attackers increasingly target unprotected east-west traffic across IT, IoT, OT, and IoMT devices. According to Forrester Research, microsegmentation has entered its 'Golden Age' as a crucial strategy for preventing lateral movement, with research showing organizations implementing comprehensive microsegmentation solutions achieve $3.50 in value for every dollar invested. 'By integrating the extensive cyber exposure management capabilities of Armis Centrix™ with Elisity's dynamic policy engine, we're advancing network-segmentation architecture for enterprises pursuing Zero Trust maturity,' said James Winebrenner, CEO of Elisity. 'Organizations can now implement comprehensive microsegmentation in weeks instead of years, rapidly discovering every user, workload, and device on their networks and automating policies that persist wherever those devices appear.' 'Supporting our customers in solving their toughest cybersecurity challenges is our top priority,' said Nadir Izrael, CTO and Co-Founder of Armis. 'The opportunity to come together with industry peers, like Elisity, to integrate our solutions to work better together on behalf of customers makes that mission even more impactful and rewarding. We're proud of our collaboration on behalf of Main Line Health and we will continue to support them as they advance patient safety and drive operational resilience.' Teddie Wardi, Managing Director at Insight Partners, which holds investments in both companies, added, 'We've seen firsthand how microsegmentation projects often falter due to implementation challenges. This partnership between Armis and Elisity addresses this market gap by delivering a solution that can be quickly and effectively implemented and scaled across thousands of IT and OT environments. The combination of comprehensive cyber exposure management with identity-based microsegmentation creates immediate value for enterprises seeking to enhance their security posture.' The successful deployment at Main Line Health underscores the deepening strategic integration between Armis and Elisity, focused on collaborating to address critical enterprise security gaps. This integration represents a significant joint investment, uniting Armis' leadership in cyber exposure management with Elisity's leading identity-based microsegmentation to deliver a powerful framework for organizations pursuing Zero Trust maturity. Both companies are committed to continued collaboration to enhance security postures for joint customers facing increasingly complex threats. This bidirectional integration works by synchronizing Armis' comprehensive asset intelligence and risk quantification with Elisity's identity-based microsegmentation and dynamic policy engine, the integration provides enhanced situational awareness and enables the enforcement of least-privilege access policies crucial for protecting complex environments. This collaboration strengthens defenses against evolving cyber threats. Learn more about the integration, including the bidirectional data flow and its impact on healthcare security, on the Elisity blog: To schedule a demonstration or book a meeting at RSAC 2025, visit About Elisity Elisity is a leap forward in network segmentation architecture and is leading the enterprise effort to achieve Zero Trust maturity, proactively prevent security risks, and reduce network complexity. Designed to be implemented in weeks, without downtime, upon implementation, the platform rapidly discovers every user, workload, and device on an enterprise network and correlates comprehensive insights into the Elisity IdentityGraph™. This empowers teams with the context needed to automate classification and apply dynamic security policies to any device wherever and whenever it appears on the network. These granular, identity-based microsegmentation security policies are managed in the cloud and enforced using your existing network switching infrastructure in real-time, even on ephemeral IT/IoT/OT devices. Founded in 2019, Elisity has a global employee footprint and a growing number of customers in the Fortune 500.
CBS News
11-03-2025
- Health
- CBS News
Riddle Hospital President Shelly Buck shares journey from nurse to executive
There aren't that many women who are presidents of hospitals, but Riddle Hospital President Shelly Buck knows all about breaking boundaries. Research shows only about 14% of hospital CEOs are female. But Buck, who started her career as a nurse, has broken the glass ceiling. "I've experienced some challenges that you normally wouldn't have in your career," Buck said. "It's been interesting to say the least." Right after Buck assumed the position, the COVID-19 pandemic shut down the world. She managed Riddle's pandemic response while also overseeing a major expansion of Riddle, part of Main Line Health. The once sleepy little hospital has grown into a thriving medical campus in Media. "The best reward has been seeing the transformation of Riddle Hospital without losing its core," Buck said. "The values, the commitment to the community, the support of the community, the employees here." A grand mosaic in the lobby shows the Delaware County community around the hospital, with thousands of tiles decorated with pictures and words like hope, unity and excellence. "This mosaic is a reflection of the hospital, also the community that we serve," Buck said. Buck started her professional life as a nurse and says service is in her blood. "The fact that I'm a registered nurse, I think I bring a little bit of a different perspective to the role," she added. "I can tell you it wasn't a straight shot [to get here], that's for sure. I tell people I serpentined to get here. ... When I first started out as nursing, I didn't aspire to be, you know, the president of a hospital or CEO or anything like that. That was not my dream. I just knew that I wanted to provide good quality care to every person that I touched. And the opportunities just kind of came my way." Now Buck is committed to making more opportunities for others, especially women. "We need more women, more nurses, I would say even, in health care, in leadership positions as presidents, as CEO. ... I just get so much joy in doing this work, because I know it's bigger than me. It's not just about me, it's about those lives that are entrusted in our hands."
